VAISHALI PHARMA
Back to Cashflow Statement
|
VAISHALI PHARMA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.42 Cr | ₹-1.73 Cr | ₹0.42 Cr | ₹-1.81 Cr | ₹-3.14 Cr |
What is the latest Cash Flow from Financing Activities ratio of VAISHALI PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2024 | ₹-1.42 Cr |
| Mar2023 | ₹-1.73 Cr |
| Mar2022 | ₹0.42 Cr |
| Mar2021 | ₹-1.81 Cr |
| Mar2020 | ₹-3.14 Cr |
How is Cash Flow from Financing Activities of VAISHALI PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2024 | ₹-1.42 Cr | Negative | |
| Mar2023 | ₹-1.73 Cr | Negative | |
| Mar2022 | ₹0.42 Cr | Positive | |
| Mar2021 | ₹-1.81 Cr | Negative | |
| Mar2020 | ₹-3.14 Cr | - | |
Compare Cash Flow from Financing Activities of peers of VAISHALI PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VAISHALI PHARMA | ₹125.7 Cr | 0.4% | -10.4% | -47.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,419.0 Cr | 3.5% | 6.2% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,857.0 Cr | -2.7% | -0.7% | 11% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,953.0 Cr | 0.6% | 9.1% | 19.7% | Stock Analytics | |
| CIPLA | ₹123,722.0 Cr | 1.2% | -1.4% | -4.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,906.0 Cr | 3.9% | 0.6% | -3.7% | Stock Analytics | |
VAISHALI PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VAISHALI PHARMA | 0.4% |
-10.4% |
-47.5% |
| SENSEX | 1.6% |
2.7% |
6.3% |
You may also like the below Video Courses